Obesity paradox in patients with non-small cell lung cancer treated with immunotherapy Correspondence

  

Authors:	Sanchez, A.; Furberg, H.
Title:	Obesity paradox in patients with non-small cell lung cancer treated with immunotherapy
Keywords:	cancer chemotherapy; protein expression; treatment outcome; disease course; cancer staging; letter; c reactive protein; disease association; cancer immunotherapy; computer assisted tomography; gene expression; cell infiltration; morbidity; obesity; angiogenesis; renal cell carcinoma; lung metastasis; body mass; adverse outcome; body size; immunocompetent cell; predictive value; adipose tissue; skeletal muscle; programmed death 1 ligand 1; non small cell lung cancer; tumor microenvironment; clinical trial (topic); human; neutrophil lymphocyte ratio; atezolizumab; body build
Journal Title:	JAMA Oncology
Volume:	6
Issue:	6
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2020-01-01
Start Page:	940
End Page:	941
Language:	English
DOI:	10.1001/jamaoncol.2020.0634
PUBMED:	32324195
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084149265&doi=10.1001%2fjamaoncol.2020.0634&partnerID=40&md5=fabbc4ec3bd694efd122f1953539c111
Notes:	Letter -- Export Date: 1 July 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/167487